GlassScriptPhysician profile
Benjamin Noor
NPI 1275037814
$5,882.19
in general payments reported to CMS, 2019-2025
27 companies · $1,604 in 2025
The $1,604 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $834 · 2023: $1,985 · 2024: $1,271 · 2025: $1,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,736 · Grant: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,735.81 |
| Grant | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,466.53 | 2021-2025 | Emblem Mri S-Icd, General - Tachy, General - Therapies |
| Amgen INC. | $536.91 | 2021-2024 | Repatha |
| Pfizer INC. | $503.52 | 2021-2024 | |
| Medtronic, INC. | $474.23 | 2025 | Symplicity G3, Micra, Corevalve Evolut R |
| Abbott Laboratories | $453.37 | 2023-2025 | Navitor, Xience Skypoint, Coroflow |
| Shockwave Medical, INC | $316.26 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $250.28 | 2022-2024 | Xarelto |
| Heartflow, INC. | $229.46 | 2022-2025 | |
| Inari Medical, INC. | $189.75 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $189.41 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $174.83 | 2022-2023 | Lifevest |
| Scpharmaceuticals INC. | $147.47 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $147.26 | 2023-2024 | |
| Abiomed | $132.71 | 2022 | |
| Novo Nordisk INC | $123.40 | 2022-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $119.97 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $96.71 | 2022-2025 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $66.97 | 2022-2023 | Evkeeza |
| Terumo Medical Corporation | $57.13 | 2023 | Tr Band |
| United Therapeutics Corporation | $42.20 | 2023 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.53 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $29.40 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $23.52 | 2024 | |
| Ge Healthcare | $22.28 | 2025 | |
| Irhythm Technologies, INC. | $21.08 | 2024 | Zio Xt Patch, Zio Monitor |
| Baxter Healthcare | $19.09 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Chiesi USA, INC. | $14.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Noor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.